(Q35171808)

6 August 2017

1 reference

title

Review article: botulinum toxin in the therapy of gastrointestinal motility disorders (English)

1 reference

6 August 2017

1 reference

Gui D

1

1 reference

6 August 2017

Rossi S

series ordinal

2

1 reference

6 August 2017

Runfola M

series ordinal

3

1 reference

6 August 2017

Magalini SC

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Alimentary Pharmacology & Therapeutics

6 August 2017

published in

1 reference

6 August 2017

volume

18

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

1-16

1 reference

Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Long-term results and complications of botulinum A toxin in the treatment of blepharospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Botulinum, Toxin Therapy of Eye Muscle Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Botulinum toxin A in the therapy of mimic facial lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Cricopharyngeal myotomy: indications and technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Endoscopic botulinum toxin injection for cricopharyngeal dysphagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Pneumatic dilatation is effective long-term treatment for achalasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Treating achalasia: from whalebone to laparoscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Pneumatic dilation in achalasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

A decision analysis of the optimal initial approach to achalasia: laparoscopic Heller myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation, or botulinum toxin injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

100 consecutive minimally invasive Heller myotomies: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Intrasphincteric botulinum toxin for the treatment of achalasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

A cost-minimization analysis of alternative treatment strategies for achalasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Intrasphincteric botulinum toxin type A for the diagnosis of sphincter of Oddi dysfunction: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Open lateral sphincterotomy is still the best treatment for chronic anal fissure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Laparoscopic surgery for gastro-oesophageal reflux: beyond the learning curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Isosorbide dinitrate in the treatment of anal fissure: a randomised, prospective, double blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

A comparison of botulinum toxin and saline for the treatment of chronic anal fissure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Treatment of proctalgia fugax with botulinum A toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Botulin toxin in the treatment of nonrelaxing puborectalis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Lack of response to botulinum toxin A in patients with hypertrophic pyloric stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Botulinum toxin for chronic anal fissure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

Botulinum Toxin Injections in the Internal Anal Sphincter for the Treatment of Chronic Anal Fissure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01598.X

10.1046/J.1365-2036.2003.01598.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference